What Medical Care Corporation does

Medical Care Corporation is a privately held California corporation founded in 1999 and headquartered in Newport Beach, operating the MCI Screen, a web-based cognitive screening platform for Alzheimer's disease, dementia, depression, and related neurological or psychological conditions. The platform is delivered as a self-service consumer web application backed by the Infoducer Suite for account management, with users registering directly at mciscreen.com, taking tests online, and receiving results via email; the site implements encrypted data transmission, user authentication, and HIPAA-compliant handling of Protected Health Information through a Business Associate Agreement framework. The company monetizes via an annual subscription access model governed by a 2024 Pricing Policy and acquires users through healthcare provider referrals, organic search, and earned media exposure on outlets including the CBS Early Show, Oprah, and the Today Show. In 2021 the entity was rebranded as Embic Corporation, which now ensures ongoing access to MCI Screen and preservation of prior patient data and assessment reports; no institutional funding, revenue, or headcount growth signals are disclosed in the available data, and the company is listed at 11-50 employees.

Name

Medical Care Corporation

Legal name

Medical Care Corporation

Website

https://mccare.com

Company type

Private

Founded year

1999

Operating status

Acquired

Headcount range

11–50 employees

Short description

Medical Care Corporation, founded in 1999 and now operating as Embic Corporation, runs MCI Screen, a HIPAA-compliant, self-service web platform that delivers cognitive screening assessments for Alzheimer's, dementia, and depression to individual consumers and healthcare providers via annual subscriptions.

Ownership category

akta.pro rank

Product category

Digital Cognitive Health Screening

NAICS

Medical Laboratories (621511)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industry

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Cognitive health screening
• Alzheimer's disease assessment
• Memory impairment testing
• Digital cognitive diagnostics
• Neurological screening tools

Headquarters

HQ city

Newport Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. MCI Screen Access: Users create accounts and access various cognitive tests and results through the MCI Screen platform. Pricing referenced in 2024 Pricing Policy document.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Medical Care Corporation provides the MCI Screen, a web-based cognitive screening platform that allows individuals to self-administer tests for Alzheimer's disease, dementia, depression, and related neurological or psychological conditions. Users create accounts on mciscreen.com, complete assessments through the Infoducer Suite, and receive results via email to share with their healthcare providers. The platform supports longitudinal tracking of patient data and assessment reports over time.

Product overview

Medical Care Corporation offered a single product, the MCI Screen, a cognitive screening platform for assessing Alzheimer's disease, dementia, depression and related neurological conditions. The company has since rebranded as Embic Corporation, with the MCI Screen now accessible through mciscreen.com. The product operated through the Infoducer Suite, a login and account management system that allowed users to register, take tests, and receive assessment reports.

Differentiator

Problem solved

Functional benefit

Products and services

• MCI Screen A web-based cognitive screening and assessment tool for Alzheimer's disease, dementia, depression and related conditions. Users create accounts on mciscreen.com, self-administer tests through the Infoducer Suite, and receive results via email that they can share with their healthcare providers. The platform supports longitudinal tracking of patient data and assessment reports.

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Eisai: Eisai is a major pharmaceutical company with leading Alzheimer's disease therapeutics (Leqembi partnership with Biogen), making it a broad incumbent whose commercial focus on early detection elevates demand for screening tools like MCI Screen.
• Biogen: Biogen is a large biopharmaceutical company developing and commercializing Alzheimer's therapeutics (e.g., Aduhelm, Leqembi); it represents a broad incumbent in the Alzheimer's treatment ecosystem that touches screening and downstream patient identification relevant to MCI Screen.

Emerging players

• Posit Science (BrainHQ): Posit Science's BrainHQ platform offers computerized cognitive training and assessments, partially overlapping with MCI Screen in the consumer cognitive health category but differentiated by training rather than screening.
• Cerveau Technologies: Cerveau supplies tau imaging biomarkers used in Alzheimer's disease research and drug development, an adjacent and enabling player in the cognitive diagnostics value chain that intersects with MCI Screen's screening focus.

Direct peers

• Neurotrack: Neurotrack offers a digital cognitive assessment and brain health program for early detection of memory decline and Alzheimer's, overlapping with MCI Screen's consumer-facing cognitive screening value proposition.
• Altoida: Altoida provides a digital cognitive assessment platform leveraging augmented reality and AI to detect early signs of cognitive decline and Alzheimer's disease, directly competing with MCI Screen in consumer and clinical cognitive screening.
• Cogstate: Cogstate provides computerized cognitive testing for clinical trials, healthcare, and concussion assessment, with a self-service/online testing model that overlaps with MCI Screen's cognitive assessment delivery approach.
• BrainCheck: BrainCheck provides a digital cognitive assessment and brain health platform used by clinicians and consumers for concussion, dementia, and normal aging screening, directly comparable to MCI Screen's cognitive screening focus.
• Linus Health: Linus Health offers a digital cognitive assessment platform (including DCTclock and Brain Health Platform) used by clinicians and researchers for early detection of Alzheimer's and other dementias, serving a similar screening use case as MCI Screen.
• Cambridge Cognition: Cambridge Cognition delivers digital cognitive assessment tools for clinical trials, healthcare, and research, competing with MCI Screen in computerized neuropsychological testing for memory and dementia screening.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Care Corporation